GLP-1 medicines semaglutide and tirzepatide reduce the risk of heart failure hospitalization and death by over 40% in patients with heart failure with preserved ejection fraction finds this new study in JAMA
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
Hundreds of weight loss and diabetes jab users report pancreas problems. Some cases of pancreatitis reported to be linked to GLP-1 medicines have been fatal.
